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Enzymatic biofuel cells (EBFCs) can generate energy from metabolites present in physiological ﬂuids.
They represent an attractive alternative to lithium batteries to power implantable devices, as they work
at body temperature, are light and easy-to-miniaturise. To be implantable in blood vessels, EBFCs should
not only be made of non-toxic and biocompatible compounds but should also be able to operate in
continuous ﬂow-through mode. The EBFC devices reported so far, however, implement carbon-based
materials of questionable toxicity and stability, such as carbon nanotubes, and rely on the use of external
redox mediators for the electrical connection between the enzyme and the electrode. With this study, we
demonstrate for the ﬁrst time continuous power generation by ﬂow through miniature enzymatic biofuel
cells fed with an aerated solution of glucose and no redox mediators. Non-toxic highly porous gold was
used as the electrode material and the immobilisation of the enzymes onto the electrodes surface was
performed via cost-effective and easy-to-reproduce methodologies. The results presented here are a
signiﬁcant step towards the development of revolutionary implantable medical devices that extract the
power they require from metabolites in the body.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Millions of patients worldwide suffer from serious diseases
such as bradycardia, ﬁbrillation or diabetes, and consequently re-
quire active medical implants (WHO 2014). Size, weight, and re-
liability are fundamental characteristics of these devices, and are
typically determined by the power source utilised. Active medical
implants are traditionally powered by lithium batteries, which are
heavy and difﬁcult to miniaturise, leading to disproportionately
large energy sources compared to the systems that they power
(Bazaka and Jacob 2012). The search for alternative power sources,
which are light, non-toxic, and easy-to-miniaturise, is therefore
crucial.
Enzymatic biofuel cells (EBFCs) are power sources that can be
employed in the human body (Barton et al. 2004). EBFCs are a
speciﬁc type of fuel cell that implements redox enzymes as cata-
lysts at the anode and cathode. They can mimic many of the me-
tabolic pathways found within living cells (in particular the oxi-
dation of glucose), and thus produce power from energy sources
naturally found in biological ﬂuids at body temperature (Cosnier
et al. 2014). EBFCs have also the added beneﬁt of producing the
same waste products as the living organism that hosts them, andr B.V. This is an open access article
orenzo).could thus use established waste metabolism routes to dispose of
the by-products produced during the production of power. These
features make EBFCs an attractive alternative to lithium batteries.
For the purpose of in vivo use, EBFCs could either be implanted
in soft tissue or in blood vessels (Barton et al., 2004; Cinquin et al.,
2010; Kerzenmacher et al., 2008). In the case of devices to be
implanted in the soft tissue, the system is limited by lower fuel
and oxidant concentrations (glucose and oxygen), and is thus re-
liant solely on diffusion for the supply and removal of reactants
and waste products respectively. Devices designed for use in blood
vessels, would instead exhibit continuous ﬂow through operation.
In this case, the EBFC would beneﬁt by having higher concentra-
tions of glucose and oxygen, continuously supplied by the ﬂow of
blood. The continuous ﬂow could however lead to enzyme
leaching from the electrodes, and could interfere with the electron
transfer between enzymes and the electrode surface (Ker-
zenmacher et al., 2008).
Currently the practical application of EBFCs is prevented by
several major hindrances, the most signiﬁcant of which are poor
stability and extremely low power yields (Wei and Liu, 2008).
However, the poor stability is not necessarily caused by the de-
activation of the enzymes used, but rather by a decay in the efﬁ-
ciency of electron transfer between the enzymes and the electrode
surface. This is due to the fact that most EBFCs reported so far rely
on mediated electron transfer (MET) techniques, which typically
require foreign redox active particles to transfer electrons betweenunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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et al., 2008; Degani and Heller, 1987; Minteer et al., 2007). Over
time, these free moving redox mediators can leach out from the
fuel cell's electrodes causing a decay in power output.
The development of new enzyme immobilisation techniques in
recent years, which achieve direct electron transfer (DET) between
the enzyme and the electrode, together with major advances in
material sciences allowing for much higher enzyme loading, and
advances in electronics leading to ultra-low power medical de-
vices (with a typical pacemaker now only requiring 10 mW) have
opened new perspectives and reinforced the interest for EBFCs
(Cosnier et al., 2014).
Power generation by EBFCs from biological ﬂuids has been re-
cently proven (Kim et al., 2006; Rincón et al., 2011; Sokic-Lazic and
Minteer, 2009; Togo et al., 2007). Nonetheless, there is currently
very little reported on fully-ﬂedged devices capable of continuous
operation under physiological conditions. The majority of devices
reported so far show the use of separate enzymatic electrodes
simply placed in the living organism and externally wired. In the
case of continuous ﬂow-through operation, these devices still rely
on the use of mediators in the feed solution. There are no reported
EBFCs that exhibit continuous ﬂow-through operation without
mediators for the potential use in line with blood vessels. Instead
the few studies that have progressed to the development of de-
vices capable of sustained operation have thus far focused on
implantation in the soft tissue of animals (Castorena-Gonzalez
et al., 2013; Cinquin et al., 2010; Halámková et al., 2012; MacVittie
et al., 2013; Rasmussen et al., 2012; Sales et al., 2013; Szczupak
et al., 2012).
All of these reported studies rely on the use of carbon-based
electrodes. In particular, carbon nanotube (CNT) aggregates have
been widely implemented, since they allow DET with glucose
oxidase (GOx), which is the most prevalent enzyme used for glu-
cose oxidation at the anode of EBFCs (Anthony et al., 2002; Ivnitski
et al., 2006; Liu et al., 2005). However, the long term toxicity and
stability of CNTs is still unknown. CNTs have been reported to
cause the destruction of T lymphocyte cells in mammals (Bottini
et al., 2006). Direct contact between the CNTs electrode and
physiological ﬂuids should therefore be carefully prevented in
implantable applications. Some researchers have tackled this ob-
stacle by enclosing their devices in semi-permeable membranes
which would prevent direct contact between the electrodes and
white blood cells (Cinquin et al., 2010). This may, however, not be
possible when designing a device for implantation in or around
blood vessels, since the device would have to be small enough to
cause minimal disruption to normal blood ﬂow. The search for
electrode materials, as an alternative to carbon-based systems is
therefore critical for implantable EBFCs. In this context, highly
porous gold (hPG) electrodes are a promising alternative. These
non-toxic electrodes have remarkable properties, such as high
conductivity, large surface area, three-dimensional open porosity,
and biocompatibility. Moreover, their large surface area and foam-
like morphology make hPG electrodes the ideal support for en-
zyme immobilisation at high loadings as previously demonstrated
by this group and others (Chen et al., 2012; du Toit and Di Lorenzo,
2014b; Hakamada et al., 2012; Xiao et al., 2013).
In this study, we demonstrate for the ﬁrst time sustained power
production from continuous ﬂow-through enzymatic biofuel cells
(CFEBFCs) for periods of up to one month without the use of ex-
ternal redox mediators. We also demonstrate a simple and low
cost methodology for fast prototyping of CFEBFCs using 3D printed
moulds, as well as the electrochemical production of hPG elec-
trodes without the need for potentiostatic control. Moreover, GOx,
implemented at the anode, is electrostatically immobilisation onto
the hPG surface via the simple and easy-to-reproduce method that
we have previously reported (du Toit and Di Lorenzo, 2014b).2. Experimental
2.1. Materials
GOx from Aspergillus niger, laccase (LAC) from Rhus vernicifera,
and all other reagents used were of analytical grade and purchased
from Sigma-Aldrich. Unless stated otherwise, all the aqueous so-
lutions used were prepared with reverse osmosis puriﬁed water.
Saturated calomel electrodes (SCE) were purchased from IJCam-
bria Ltd. Platinum wire was purchased from Cookson Precious
Metals Ltd. Polydimethylsiloxane (PDMS, Dow Corning Sylgard
184) was purchased from Ellsworth Adhesives.
All analytical experiments were performed in phosphate buf-
fered saline (PBS). This was prepared with the following con-
stituents: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM
KH2PO4. The pH of this solution was then adjusted to 7 with the
drop wise addition of 1 M solutions of HCl and NaOH.
All potentiostatically-controlled electrochemical processes
were conducted using the Autolab PGSTAT128 N (Metrohm, UK)
potentiostat. The load on the fuel cells was controlled using a
Cropico variable resistance box (RS Components) and the potential
difference was monitored and recorded using a PicoLog ADC-24
multichannel data logger. The moulds for the PDMS replicas were
3D printed in polylactic acid using a Makerbot Replicator.
2.2. Deposition of hPG onto platinum wires
The hPG was fabricated with a two-stage process similar to the
process previously described (du Toit and Di Lorenzo, 2014a).
Brieﬂy, controlled lengths of platinum wire electrodes were im-
mersed in an electrolyte consisting of 0.1 M HAuCl4 and 1 M
NH4Cl. Gold was deposited in two steps. For platinumwire lengths
of 1 cm or less, the working potential was ﬁrst gradually stepped
down to 4.0 V (vs. SCE) over a period 10 s using the Autolab
PGSTAT128N (Metrohm, UK) potentiostat. This potential was then
maintained for a further 10 s. For platinum wire lengths greater
than 1 cm (where the required deposition current exceeded the
capabilities of the potentiostat), a simple two-electrode system
was used with a second platinum wire as the counter electrode.
This time the potential applied across the two electrodes was
gradually stepped down to 10 V and then maintained at this
potential for 10 s using the Basetech BT-305 variable bench-top
power supply unit. This was done in accordance with the actual
potential applied across the working electrode and counter elec-
trode when using a potentiostat with a three-electrode setup.
The morphology of the resulting electrodes was characterised
using a Hitachi S-4300 ﬁeld emission scanning electron micro-
scope (FESEM).
2.3. Enzyme immobilisation onto hPG electrodes
GOx and LAC were immobilised onto the hPG anode and
cathode respectively to facilitate the oxidation of glucose at the
anode and the reduction of oxygen at the cathode according to the
following reactions:
 
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GOx was electrochemically adsorbed onto the prepared hPG
wire electrodes using a process based on the method described
previously (du Toit and Di Lorenzo, 2014b). Simply, 6 CV scans
were conducted between 0.42 V and 0.60 V (vs. SCE) at a scan rate
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proximately 270 U ml1 as per activity rating of manufacturer).
LAC was immobilised using a multistage method based on a
method previously reported by this research group and a thiol
blotting method reported by other researchers for the im-
mobilisation of laccase from Trametes versicolor (du Toit and Di
Lorenzo, 2014b; Pita et al., 2011). The surface of the hPG wire
electrodes was modiﬁed with a layer of amino-phenyl groups
through a simple two-stage process. Firstly, a layer of nitro-phenyl
groups was attached by performing two reductive CV scans at
100 mV s1 from 0.6 V to 0.6 V (vs. SCE), in the presence of an
acetone electrolyte containing 2 mM p-nitrophenyldiazonium
tetraﬂuoroborate and 100 mM tetrabutylammonium tetra-
ﬂuoroborate. In the second stage, the nitro groups were exchanged
for amino groups by conducting two reductive CV scans at
50 mV s1 from 0.0 V to 1.4 V (vs. SCE), in an electrolyte con-
taining 10%v/v EtOH and 0.1 M KCl. Afterwards, the electrodes
were transferred to a solution containing 10 mM 6-mercapto-1-
hexanol and left overnight at room temperature. The following
morning 1 mg of LAC (270 U as per activity rating of manufacturer)
was added to 0.38 ml of a 50 mM sodium periodate solution. After
30 minutes of incubation at room temperature this LAC solution
was made up to 1.0 ml by the addition of 0.62 ml of a 100 mM
Na2HPO4 solution. The amino-phenyl and thiol functionalised hPG
electrodes were then submerged in this LAC solution for 90 min.
Finally the electrodes were taken from the LAC solution and, after
repeated rinsing in a 10 mM 2-morpholinoethanesulfonate (MES)
buffer, were submerged in a solution containing 10 mM MES,
20 mM N-hydroxysuccinimide and 40 mM 1-(3-dimethylamino-
propyl)-3-ethylcarbodiimide for 2 h before being rinsed with and
stored in PBS until required.Fig. 1. Schematic and construction of the two different CFEBFC conﬁgurations; (A) par
electrodes (top view), (C) casting of PDMS channels from 3D printed negative, (D) expl3. Results and discussion
3.1. Enzymatic biofuel cell fabrication
Two different CFEBFC designs were considered in this study. In
the ﬁrst design, the anode and the cathode (1 cm long each) were
ﬁt in two parallel channels, each with a 3 mm3 mm cross-sec-
tional area, separated by a PDMS wall (Fig. 1A). The second design
was characterised by a single channel (10 mm3 mm cross-sec-
tional area) containing the two electrodes, which were positioned
so that the electrolyte would ﬂow over the cathode and the anode
sequentially (Fig. 1B). In this design, the electrode's projected
surface area was increased by repeatedly folding 3 cm long elec-
trodes to occupy a total cross-sectional area of 1 cm by 0.5 cm. The
negative of the CFEBFC was 3D printed and then used as a mould
over which PDMS was cast to create the ﬁnal fuel cell design
(Fig. 1C). Once the enzymatic electrodes were inserted, the PDMS
structure was clamped between two pieces of acrylic plastic
(Fig. 1D).
The electrodes were manufactured by directly electrodeposit-
ing hPG ﬁlms onto platinum wires via a hydrogen bubble template
(du Toit and Di Lorenzo, 2014a). This technique relies on the si-
multaneous deposition of gold and evolution of hydrogen gas, and
thus is reliant on relatively high deposition potentials and cur-
rents. The deposition is therefore easy to achieve and control with
a potentiostat in the case of small test electrodes (such as for the
electrodes used in the parallel channels design). When larger
surfaces are used, such as the platinum wires used in the single
channel design, potentiostatic control is, however, harder to
maintain. The use of a DC power supply as an alternative to the
potentiostat was therefore investigated to simplify the established
hPG deposition method. Fig. 2 compares the FESEM images of theallel channel fuel cell design (top view), (B) single channel fuel cell with pleated
oded view of a CFEBFC.
Fig. 2. Electrode conﬁgurations and their respective morphologies as shown by
FESEM (A) dual channel fuel cell with hPG electrodes produced under potentio-
static control and (B) single channel fuel cell with pleated hPG electrodes produced
under manual control with bench-top DC power supply.
Fig. 3. Polarisation by fuel cell load of both CFEBFC conﬁgurations (A) parallel channel C
24 h after setup. Current and power densities refer to geometric surface area of anode
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tained either via a potentiostatically controlled electrodeposition
(Fig. 2A), or by using a DC power supply (Fig. 2B). As shown, the
two methodologies led to the same porous structure. This is a
signiﬁcant move towards the low cost production of hPG electro-
des on a larger scale.
3.2. Performance of the CFEBFCs
The CFEBFCs were tested by continuously feeding themwith an
aerated PBS solution containing 27 mM glucose, at a rate of
0.35 ml min1 and under the constant temperature of 37 °C as
shown in Supplementary data.
The performances of the two CFEBFCs were ﬁrstly compared on
the basis of their polarisation and power curves. These were ob-
tained by step-increasing the resistance applied across the fuel cell
between 1 kΩ and 1 MΩ, as well as by measuring the open circuit
potential (OCP). Fig. 3 shows the results obtained. A marked dif-
ference in performance (either speciﬁc by electrode surface area,
or overall) was observed between the two CFEBFCs. The power and
current density obtained with the single channel CFEBFC (Fig. 3B)
are in fact much lower than the case of two channels CFEBFC
(Fig. 3A).
Moreover, in the case of the single chamber CFEBFC, a drop in
OCP of approximately 90 mV was observed. The potential inter-
ference of reaction intermediates, such as H2O2, could be the cause
of the poorer performance of the single chamber CFEBFC. H2O2 is
produced when reduced GOx comes in contact with oxygen as
described by the following reactions:
   
C H O GOx C H O GOx. H6 12 6
glucose
6 10 6
D glucono 1,5 lactone
2+ → +
− − −
GOx. H O GOx H O2 2 2 2+ → +
This poses no problem at the GOx electrode as H2O2 is can be
involved in improving electron mediation between the enzyme's
active site and the hPG surface, according to the following reac-
tion:
H O O 2H 2e2 2
hPG electrode
2→ + ++ −
The back diffusion of H2O2 can however cause interference at
the LAC electrode by causing an electrochemical short-circuit.
Laccase could also be deactivated by H2O2 as previously reported
(Milton et al. 2013). Enzyme migration from one electrode to an-
other could also be a risk. If, as a consequence of the continuousFEBFC and (B) single channel CFEBFC. Tests performed during continuous operation
(0.31 cm2).
Fig. 5. Power output observed at different ﬂow velocities with each CFEBFC con-
ﬁguration. Testing performed on fuel cells which had already operated con-
tinuously for 24 h. Note that ﬂow velocity is on logarithmic scale.
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tion it could be absorbed into the porous structure of the following
electrode with the result of short-circuiting the electricity pro-
duction. In our case, however, this risk is believed to be minimal
since the electrodes were rinsed thoroughly prior to use to remove
any poorly attached enzyme. Moreover, the single channel CFEBFC
was set-up so that the feed would ﬁrst pass over the cathode and
then to the anode. This was done on the assumption that, the LAC,
covalently attached to the electrode contrarily to GOx, presented
minimum risk of leaching.
The speciﬁc power output by the geometric surface area of an
electrode is the most common metric used for determining fuel
cell performance, however it does not always have practical re-
levance. In this study, the highest speciﬁc power output by anode
surface was obtained with the parallel channels CFEBFC; with a
value (1.6 μW cm2) more than two times greater than the single
channel CFEBFC (0.7 μW cm2). Nonetheless, since the parallel
channels CFEBFC is reliant on the use of a physical divider between
electrodes, it has a larger overall volume relative to the electode
size. A more practical evaluation of the CFEBFCs’ performance
should therefore consider not only the surface area of the elec-
trodes but also the overall size and shape of the constructed fuel
cells.
The overall polarisation of a fuel cell can also give a misleading
characterisation of the fuel cells since it only takes a snapshot of
their performance. The power produced by the two types of fuel
cells was therefore investigated during continuous operation.
Fig. 4 shows the average continuous power production from
the two CFEBFC designs during the ﬁrst 24 h of operation. In each
case, the fuel cell load was chosen so as to maximise power output
(30 kΩ and 10 kΩ for the parallel channel and the single channel
CFEBFC respectively). According to the parameter used for com-
parison, the two designs give apparently controversial results.
When the speciﬁc power output is considered, the parallel channel
CFEBFC consistently outperforms the single channel CFEBFC
(Fig. 4A). On the contrary, when the total power produced is taken
into account, the single channel system presents better perfor-
mance than the parallel channel system (Fig. 4B). This suggests
that there is a potential trade-off between the CFEBFC's speciﬁc
power output by area and its speciﬁc power output by volume.
Alternatively, assuming that H2O2 is the cause for the lower
power density by electrode area for the single chamber system,Fig. 4. Power output from the two CFEBFC designs over the ﬁrst 24 h of operation; (A) sp
from the CFEBFCs. In both cases data is taken from 3 replicate fuel cells as representedthe use of a physical divider could be overcame by operating the
cell at ﬂow velocities high enough to counteract H2O2 diffusion.
The CFEBFCs were in fact fed with the same volumetric ﬂow rate
(0.35 ml min1). Due to their different cross-sectional areas, the
ﬂow velocities in the CFEBFCs were however different:
1.94 cm min1 and 1.17 cm min1 for parallel channels CFEBFC
and single channel CFEBFC respectively. This difference could af-
fect the mass transfer both from the bulk of the solution to the
enzymes on the electrodes, and subsequently between the en-
zymes and the hPG. The impact that different ﬂow velocities have
on the power output generated by the two CFEBFCS was conse-
quently investigated.
Fig. 5 shows the power output produced by the two CFEBFCs at
increasing velocities of ﬂow. As shown, differences in ﬂow velocity
had little effect on the parallel channels CFEBFC. On the other
hand, exponential increases of the ﬂow velocities had a signiﬁcant
impact on the performance of the single chamber CFEBFC. It has
been reported that the GOx's apparent Km (which inversely in-
dicates enzymes’ afﬁnity for glucose) increases with ﬂow rateeciﬁc power output by geometric surface areas of anodes, (B) absolute power output
by standard deviation error bars in Fig. 4A.
Fig. 6. Power output during continuous operation over 1 month period. Dashed
line indicates theoretical power output based on half-life of 8 days. Flow rate:
0.35 ml min1.
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expected at high ﬂow rates. This decay was observed in the case of
the parallel channel CFEBFC. Contrarily, in the case of the single
channel CFEBFC the power output increased at ﬂow velocities
higher than 0.04 cm min1. This result supports the hypothesis
that H2O2 back diffusion is one of the causes of poor performance
at low ﬂow rates. The high ﬂow rates could also provide a better
supply of reactants to hard-to-reach regions of the pleated elec-
trode surfaces owing to increased turbulent mixing. Higher ﬂow
velocities are however associated with a much higher throughput
of fuel, with exponential increases in ﬂow rate yielding only minor
increases in performance. An increase in the ﬂow velocity of one
order of magnitude (from 0.03 cm min1 to 0.7 cm min1) led in
fact to a power output only 0.75 times higher. Future work is,
however required to take a more in-depth look at the ﬂow phe-
nomena in the two cells and further investigate and quantify the
effects of ﬂow rate on their operation.
Although the initial power output generated by enzymatic
biofuel cells is frequently reported to be sufﬁcient for ultra-low
power implantable medical devices, their long-term stability
during continuous operation is very poor. Many enzymatic fuel
cells reported so far exhibit in fact a rapid decay in performance,
with most lasting only a few hours (Castorena-Gonzalez et al.,
2013; Cinquin et al., 2010; MacVittie et al., 2013; Togo et al., 2007).
In order to determine the long-term stability of the CFEBFC it was
decided to record the power output during continuous operation
for one month. To the best of our knowledge, this is the ﬁrst study
performed over such a period of time with an enzyme im-
mobilised EBFC operating in continuous ﬂow with no addition of
external mediators.
The parallel channel fuel cell was selected for this analysis since
it produced a more stable power output at low ﬂow rates with low
risk for H2O2 diffusion from the anode to the cathode.
Fig. 6 shows the continuous power production from the parallel
channel EBFC over a period of 30 days. As shown, during the ﬁrst
48 h of operation, the CFEBFC exhibited a growth in the power
produced, before entering a general decay phase. The ﬂuctuations
in the power output observed are attributed to the evolution of gas
bubbles within the fuel cell. Although every effort was taken to
prevent this happening by using drips prior to feeding the CFEBFC
(see Supplementary data), some gas bubbles would still evolve
during long-term continuous operation. A sharp drop in powerwas observed after 20 days of continuous operation, which con-
tinued until the 23rd day when the CFEBFC was washed with a
fresh PBS solution. This suggests that there might have been some
contamination in the feed that inhibited the power production.
Regardless of the short-term ﬂuctuations in the power output
from the CFEBFC, a strong trend was maintained with an apparent
constant rate of decay. From this decay, the half-life of the fuel cell
was determined to be approximately eight days. Since there is no
other research reported to have used a continuous ﬂow through
enzymatic biofuel cell or to have even tested the long-term sta-
bility for over 30 days, it is difﬁcult to make comparisons to the
existing state-of-the-art on the subject. However, it can be re-
ported that this CFEBFC has a half-life which is in line with the
half-life of free laccase in solution (3–8 days under optimal con-
ditions (Zille et al., 2003)), and also with that of a carbon-based
GOx-LAC fuel cell (approximately six days based on continuous
operation for 72 h (Chen et al., 2001)). Since GOx has reported
half-lives in excess of 200 days, the LAC electrode is likely to be the
limiting electrode and the cause of the decay in power output
(Rando et al., 1997). This result is very promising since the ma-
jority of enzyme-immobilised devices exhibit much faster decays
in power output owing to deactivation or detachment of enzymes.
The fact that the decay in power output is in line with the decay of
the enzymes themselves suggests that the methods employed for
immobilisation are stable over long periods of time. The long-term
stability of this CFEBFC could therefore be improved by simply
increasing the stability of the enzymes used, either though protein
engineering, or through cross-linking with stabilising polymers.4. Conclusions
In this study we report continuous power generation from two
innovative continuous ﬂow enzymatic biofuel cell conﬁgurations
that implement highly porous gold electrodes and glucose oxidase
and laccase as the catalysts. The fabrication methodology here
presented is cost-effective, easy-to-reproduce and fast, allowing
for large scale-production and for further in-depth investigation
on optimal electrode conﬁguration and ﬂow channel design.
By comparing the performance of the two CFEBFCS, we de-
monstrated that the power output generated is inﬂuenced by the
channel designs; shape and size of the electrodes; and ﬂow rate
through the fuel cells. The design and operation of the CFEBFC can
therefore be customised depending on the intended use. If min-
iaturisation is a major requirement, then using larger electrodes in
a single channel device will maximise power output, but this will
require high ﬂow rates. Conversely, if space is not limited, then the
speciﬁc power output can be maximised by physically separating
the anode and cathode and thus increasing the relative size of the
fuel cell.
This study also reports for the ﬁrst time the long-term stability
of a CFEBFC under continuous operation. Typically enzymatic
biofuel cells exhibit lifetimes of only a few hours owing to the
detachment or deactivation of enzymes, or commonly due to the
leaching of redox mediators. In this study, however, the power
output produced by the CFEBFC is stable during the ﬁrst 24 h of
operation. Furthermore, though decay in performance is observed
during continual use over many days, the half-life of decay is in
line with the state-of-the-art decay of the enzymes implemented
under extremely favourable conditions (e.g. aqueous conditions).Acknowledgments
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